Arcadia Biosciences (FRA:17D) Additional Paid-In Capital : €261.89 Mil(As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Arcadia Biosciences Additional Paid-In Capital?

Arcadia Biosciences's quarterly additional paid-in capital declined from Sep. 2023 (€266.46 Mil) to Dec. 2023 (€260.90 Mil) but then increased from Dec. 2023 (€260.90 Mil) to Mar. 2024 (€261.89 Mil).

Arcadia Biosciences's annual additional paid-in capital increased from Dec. 2021 (€227.90 Mil) to Dec. 2022 (€263.21 Mil) but then declined from Dec. 2022 (€263.21 Mil) to Dec. 2023 (€260.90 Mil).

Arcadia Biosciences Additional Paid-In Capital Historical Data

The historical data trend for Arcadia Biosciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcadia Biosciences Additional Paid-In Capital Chart

Arcadia Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

193.34

196.87

227.90

263.21

260.90

Arcadia Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															265.26	262.32	266.46	260.90	261.89

Arcadia Biosciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Arcadia Biosciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Arcadia Biosciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Arcadia Biosciences (FRA:17D) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Arcadia Biosciences Inc (FRA:17D) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

RKDA:USA

Address

5950 Sherry Lane, Suite 215, Dallas, TX, USA, 75225

Website

https://www.arcadiabio.com

Arcadia Biosciences Inc is a producer and marketer of innovative, plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements primarily in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care.

Arcadia Biosciences (FRA:17D) Headlines

No Headlines